Scientists have created a new powerful "masked" cancer drug. Numerous cancer treatments are notoriously harsh on the body; they assault healthy cells simultaneously with tumor cells and result in a wide range of side effects. The Pritzker School of Molecular Engineering (PME) at the University of C

A self-assembling gel that stimulates nerve regeneration has shown promise as a treatment for paralysis in mice A self-assembling gel injected at the site of spinal cord injuries in paralysed mice has enabled them to walk again after four weeks. The gel mimics the matrix that is normally found around cells, providing a scaffold that helps cells to grow.

The Gateway Pundit has reported extensively this past year on the effects of hydroxychloroquine in treating the COVID-19 virus. We knew that Dr. Tony Fauci and the medical elites conspired to ban the use of this very successful drug. We reported earlier on how Dr. Fauci used bogus studies to disqualify HCQ in treating coronavirus....

"Why is Narcan free to a dope addict but my insulin is $750 a month?" asks an online meme that has since gone viral. "Humalog cost $21 a vial in 1996 and now that same insulin is $375" claims another meme designed to call for price regulations.

The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has largely defied attempts to contain its spread by non-pharmaceutical interventions (NPIs). With the massive loss of life and economic damage, the only way out, in the absence of specific antiviral therapeutics, has been the development of vaccines to achieve population immunity.

Source: Neuroscience News A small-scale study conducted by researchers at Yale University reveals psilocybin, a naturally occurring psychedelic compound in "magic mushrooms", appears to be effective in the treatment of migraine disorders. Previous studies have shown psilocybin to show promise in the treatment of migraines and cluster headaches, but most of the results have been anecdotal.

Prof Sewell said the 'right people' are now interested in developing the potential new therapy and said progress could now move 'quite fast'. The team says human trials on terminally ill patients could begin as early as November if the new treatment passes further laboratory safety testing.